Charlotte, North Carolina-based PeraHealth has received FDA clearance for its latest product, PeraTrend, a predictive clinical surveillance tool.
“Improving quality of patient care is our focus, which is why securing clearance from the FDA, which oversees and protects public health, is a major milestone for PeraHealth and for the clinical surveillance market,” Stephanie Alexander, PeraHealth...
